Article Text

Download PDFPDF
Influenza vaccination during cancer therapy
  1. Helen Rees1,2,
  2. Marcus Andrews1,
  3. Susan Broster3,
  4. James Nicholson3,
  5. Roderick Skinner4,
  6. Julia Chisholm1
  7. on behalf of the Supportive Care Group of the Children's Cancer and Leukaemia Group
  1. 1Department of Haematology/Oncology, Great Ormond Street Hospital, London, UK
  2. 2Department of Paediatric Haematology/Oncology, John Radcliffe Hospital, Oxford, UK
  3. 3Department of Paediatric Haematology/Oncology, Addenbrooke's Hospital, Cambridge, UK
  4. 4Department of Paediatric and Adolescent Oncology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
  1. Correspondence to Dr Helen Rees, Bristol Royal Hospital for Children, Upper Maudlin Street, Bristol BS2 8BJ, UK; helen.rees{at}

Statistics from

The current swine flu pandemic has brought into sharp focus the need for a robust strategy for rapid vaccination of the ‘at risk’ UK population.

Annual immunisation against seasonal influenza is recommended in UK guidelines for ‘at risk’ patients, including all children receiving chemotherapy, within 6 months of completing chemotherapy, or following haemopoietic stem cell transplant, their carers and household contacts.1 However, surveys of American2 and Australasian3 paediatric …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.